Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 30 October 2006. doi:10.1136/adc.2006.105361
Archives of Disease in Childhood - Fetal and Neonatal Edition 2007;92:F342-F346
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
adc.2006.105361v1
92/5/F342    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manning, D.
Right arrow Articles by Jane Platt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manning, D.
Right arrow Articles by Jane Platt, M.
Topic Collections
Right arrowRelated Articles

ORIGINAL ARTICLE

Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland

Donal Manning1, Peter Todd1, Melanie Maxwell2, Mary Jane Platt3

1 Department of Paediatrics, Arrowe Park Hospital, Wirral, Merseyside, UK
2 Clinical Practice Research Unit, Arrowe Park Hospital, Wirral, Merseyside, UK
3 Division of Public Health, University of Liverpool, Liverpool, UK

Correspondence to:
Donal Manning, Department of Paediatrics, Arrowe Park Hospital, Wirral, Merseyside CH49 5PE, UK; donal.manning{at}whnt.nhs.uk

Objectives: To determine the incidence of severe hyperbilirubinaemia in the newborn, and to identify associated clinical and demographic variables, and short-term outcomes.

Design: Prospective, population-based study.

Setting: UK and Republic of Ireland, between 1 May 2003 and 31 May 2005.

Participants: Infants in the first month of life with severe hyperbilirubinaemia (maximum unconjugated serum bilirubin >=510 µmol/l).

Results: 108 infants met the case definition, 106 from the UK and 2 from the Republic of Ireland. The UK incidence of severe hyperbilirubinaemia was 7.1/100 000 live births (95% CI 5.8 to 8.6). Only 20 cases presented in hospital; 88 were admitted with severe jaundice. 64 (60.4%) cases were male, and 56 (51.8%) were of ethnic minority origin. 87 (80.5%) cases were exclusively breast fed. Co-morbidity included haemolysis, dehydration, infection and bruising. 14 infants showed evidence of bilirubin encephalopathy, of whom 3 died. The UK incidence of bilirubin encephalopathy was 0.9/100 000 live births (95% CI 0.46 to 1.5).

Conclusions: This is the first large, prospective, population-based study of the incidence of severe hyperbilirubinaemia in the newborn. The clinical and demographic associations, and short-term outcomes identified, are the same as those reported recently in North America and Europe.


Keywords: Hyperbilirubinaemia; neonate; bilirubin encephalopathy; kernicterus


Related Articles

Fantoms
Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2007 92: F329. [Extract] [Full Text] [PDF]

Preventing kernicterus: a wake-up call
Kevin Ives
Arch. Dis. Child. Fetal Neonatal Ed. 2007 92: F330-F331. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
PediatricsHome page
M. Kaplan and C. Hammerman
Neonatal Hyperbilirubinemia: Don't Let Glucose-6-phosphate Dehydrogenase Deficiency off the Hook
Pediatrics, July 1, 2008; 122(1): 216 - 217.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health